Molecular Devices, Inc. Introduces SoftMax Pro 6 GxP Microplate Data Acquisition and Analysis Software
Published: Nov 27, 2012
SoftMax Pro 6 GxP Software facilitates easy upgrades for existing users from previous software versions with its unique “plug-in” feature that allows existing databases to be integrated without the need to re-establish and revalidate the whole system, thereby decreasing time and resources needed for this stage which can be costly and inefficient. A custom-designed validation package supports the software such as printable IQ-OQ worksheets, extensive tests for data analysis features, easy-to-follow instructions and ready-to-use sample data to streamline the software validation process making it easy and fast to validate this powerful data analysis tool.
The new software package also incorporates editors to enable easy creation of intricate protocols such as the Syntax Helper formula writing tool, and a robust data analysis package with over 15 curve fits that include: validated Parallel Line Analysis (PLA), 4-P, 5-P logistics, independent plot weighting, confidence interval calculations, and parameter dependencies chart, effectively eliminating the need for additional software purchase and validation.
The software is tightly aligned to FDA’s 21 CFR Part 11 guidance for electronic signature and electronic record. Security is ensured through controlled access and automatic lockout systems, while the document-based audit trail enables easy tracking and recording of actions, and granular user permissions control. A centralized administration system and flexible software design allows multiple administrators and remote management of user accounts, a great benefit to larger and multi-site organizations. Password-aging, log-on failure lockout, automatic idle log out, the ability to be used off-line and guest access are additional secure, compliance features that are unique to this software.
“Since its introduction, SoftMax Pro GxP Software has become an industry standard for microplate reader data acquisition and analysis in controlled environments,” said Brian Quast, BioResearch Director, Molecular Devices. “The upgrade to SoftMax Pro 6 GxP ensures we continue to offer the most comprehensive validation tools for our customers.”
T: +44 (0)7771 730919
At Molecular Devices
Vice President, Global Marketing
T: +1 408 747 3514
About Molecular Devices, LLC
Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics